← Browse by Condition
Medical Condition

iron deficiency

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 4, Phase 3

ClinicalMetric tracks all active clinical trials for iron deficiency sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — iron deficiency Clinical Trials

How many clinical trials are currently recruiting for iron deficiency?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for iron deficiency, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for iron deficiency?
iron deficiency research spans Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a iron deficiency clinical trial?
Eligibility criteria for iron deficiency trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Phase 4
1
Top Sponsors
China-Japan Friendship Hospital 1 trial
Oulu University Hospital 1 trial
AHS Cancer Control Alberta 1 trial

Recruiting Clinical Trials

NCT06427343 Phase 4
Recruiting
The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency
Enrollment
114 pts
Location
China
Sponsor
China-Japan Friendship Hospita...
View Trial →
NCT06115122
Recruiting
PEPPI Study: Identification of Women at Risk for Placental Dysfunction
Enrollment
3,000 pts
Location
Finland
Sponsor
Oulu University Hospital
View Trial →
NCT05407987 Phase 3
Recruiting
Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)
Enrollment
82 pts
Location
Canada
Sponsor
AHS Cancer Control Alberta
View Trial →

Related Conditions

heart failure (1) pre eclampsia (1) intrauterine growth restriction (1) polycystic ovary syndrome (1) cardiovascular diseases (1) hypertensive disorder of pregnancy (1) proteinuria in pregnancy (1) gynecologic cancer (1) anemia (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology